Fentanyl Cit 600mcg Oraltransmcsl
Overview
What is this medicine?
How to Use This Medicine
To use this medication properly, follow your doctor's instructions and read all the information provided. Place the lozenge in your mouth between your cheek and lower gum, and gently move it from side to side using the handle. Suck on the oral lozenge without chewing, breaking, or crushing it, and do not swallow it whole. After taking a dose, dispose of the handle in the trash, out of reach of children and pets. If any medication remains on the handle, rinse it with hot water before discarding to ensure the drug is fully dissolved.
Storing and Disposing of Your Medication
Store this medication at room temperature in a dry place, avoiding bathrooms. Keep it in a secure location where children cannot see or access it, and where others cannot reach it. Consider using a locked box or area to safeguard the medication. Keep all medications away from pets. Dispose of unused or expired medications by throwing them away. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposing of medications, consult your pharmacist, who may be aware of drug take-back programs in your area.
Missing a Dose
If you take this medication regularly and miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses. If you take this medication as needed, do not take it more frequently than directed by your doctor.
Lifestyle & Tips
- Do not drive or operate heavy machinery until you know how this medicine affects you, as it can cause drowsiness and dizziness.
- Avoid alcohol and other CNS depressants (e.g., benzodiazepines, sleeping pills) as they can increase the risk of serious side effects like severe drowsiness and breathing problems.
- Store this medicine securely out of reach of children and pets, preferably in a locked cabinet, due to the high risk of accidental overdose.
- Properly dispose of any unused or expired lozenges immediately by flushing them down the toilet or using a drug take-back program, as directed by your pharmacist or the medication guide.
Available Forms & Alternatives
Available Strengths:
- Fentanyl 25mcg/hr Patch
- Fentanyl 50mcg/hr Patch
- Fentanyl 75mcg/hr Patch
- Fentanyl 100mcg/hr Patch
- Fentanyl Cit 0.05mg/ml Inj, 20ml
- Fentanyl Cit 0.05mg/ml Inj, 2ml
- Fentanyl Cit 0.05mg/ml Inj, 50ml
- Fentanyl Cit 0.05mg/ml Inj, 5ml
- Fentanyl Cit 800mcg Oral Transmcsl
- Fentanyl Cit 1200mcg Oral Transmcsl
- Fentanyl Cit 600mcg Oral Transmcsl
- Fentanyl Cit 1600mcg Oral Transmcsl
- Fentanyl Cit 400mcg Oral Transmcsl
- Fentanyl Cit 200mcg Oral Transmcsl
- Fentanyl 62.5mcg/hr Patch
- Fentanyl 87.5mcg/hr Patch
- Fentanyl Cit 600mcg Oraltransmcsl
- Fentanyl Cit 800mcg Oral Transmcsl
- Fentanyl Cit 1600mcg Oral Transmcsl
- Fentanyl Cit 100mcg Tablets
- Fentanyl Cit 200mcg Tablets
- Fentanyl 37.5mcg/hr Patch
- Fentanyl 62.5mcg/hr Patch
- Fentanyl Cit 50mcg/ml Pf Inj, 1ml
- Fentanyl 12mcg/hr Patch
- Fentanyl Cit 50mcg/1ml Inj, 10ml
- Fentanyl Cit 100mcg/2ml Pf Inj, 2ml
- Fentanyl Cit 25mcg/0.5ml Pf Inj
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or fainting
Confusion
Severe constipation or stomach pain, which may indicate a severe bowel problem
Breathing difficulties, such as:
+ Trouble breathing
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Chest pain
Abnormal heartbeat (fast or slow)
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Changes in eyesight
Serotonin Syndrome: A Potentially Life-Threatening Condition
If you take this medication with certain other drugs, you may be at risk for serotonin syndrome, a severe and potentially deadly condition. Seek medical help right away if you experience:
Agitation
Changes in balance
Confusion
Hallucinations
Fever
Abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea
Upset stomach
Vomiting
Severe headache
Adrenal Gland Problems: A Rare but Serious Condition
Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Contact your doctor immediately if you experience:
Extreme fatigue or weakness
Fainting
Severe dizziness
Upset stomach
Vomiting
Decreased appetite
Other Possible Side Effects
While many people may not experience side effects or may only have mild ones, it's essential to be aware of the following possible side effects:
Dizziness
Drowsiness
Fatigue
Weakness
Dry mouth
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Headache
Feeling cold
Sleep disturbances
Excessive sweating
Irritation at the site of administration
If you're concerned about any side effects or have questions, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Extreme drowsiness or difficulty waking up
- Slow, shallow, or difficult breathing
- Blue lips or fingernails
- Pinpoint pupils
- Feeling dizzy or lightheaded when standing up
- Confusion or disorientation
- Unresponsiveness (cannot be awakened)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel blockage or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
Current use of certain medications, including buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
Presence of mouth sores, which should be discussed with your doctor
This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you have. This will help ensure your safety while taking this medication. Never start, stop, or change the dose of any medication without consulting your doctor first.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and exercise caution when climbing stairs.
Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be required to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed dose.
Additionally, regular use of opioid medications like this one can cause dependence. If you need to reduce the dose or stop taking this medication, consult your doctor first, as sudden changes may increase the risk of withdrawal or other severe problems. Follow your doctor's instructions carefully, and report any increased pain, mood changes, suicidal thoughts, or other adverse effects.
Safe Use Guidelines
Do not exceed the prescribed dose, frequency, or duration of treatment, as this may increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.
If your pain worsens, you become more sensitive to pain, or you experience new pain, contact your doctor immediately. Do not take more than the prescribed dose.
Interactions and Precautions
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this may lead to unsafe and potentially fatal effects.
This medication may increase the risk of seizures in some individuals, including those with a history of seizures. Consult your doctor to determine if you are at higher risk.
Long-term Use Considerations
Prolonged use of opioid medications like this one may lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation difficulties, contact your doctor.
Maintain good oral hygiene and schedule regular dental check-ups. If you have diabetes, inform your doctor, as some products may contain sugar.
Special Populations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, inform your doctor, as this medication can pass into breast milk and harm your baby. Seek medical attention immediately if your baby appears excessively sleepy, limp, or has breathing difficulties.
Overdose Information
Overdose Symptoms:
- Severe respiratory depression (slowed or stopped breathing)
- Extreme somnolence progressing to stupor or coma
- Skeletal muscle flaccidity
- Cold and clammy skin
- Pinpoint pupils
- Bradycardia
- Hypotension
- Circulatory collapse
- Cardiac arrest
- Death
What to Do:
Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Continue to monitor breathing and administer repeated doses of naloxone as needed. Provide supportive care (e.g., oxygen, ventilatory support). Call 1-800-222-1222 (Poison Control) for additional guidance.
Drug Interactions
Contraindicated Interactions
- Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of MAOI therapy (risk of serotonin syndrome or severe respiratory depression)
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, nelfinavir, saquinavir, troleandomycin, nefazodone) in patients not already receiving fentanyl (risk of increased fentanyl plasma concentrations and potentially fatal respiratory depression)
Major Interactions
- Other CNS depressants (e.g., benzodiazepines, other opioids, sedatives/hypnotics, general anesthetics, phenothiazines, tranquilizers, skeletal muscle relaxants, alcohol): Increased risk of respiratory depression, profound sedation, coma, and death.
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, nelfinavir, saquinavir, troleandomycin, nefazodone): Increased fentanyl exposure, leading to potentially fatal respiratory depression. If co-administration is necessary, reduce fentanyl dose and monitor closely.
- Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol, linezolid): Risk of serotonin syndrome.
- Mixed agonist/antagonist opioids (e.g., pentazocine, nalbuphine, butorphanol, buprenorphine): May reduce the analgesic effect of fentanyl or precipitate withdrawal symptoms.
Moderate Interactions
- Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil, fluconazole, grapefruit juice): Increased fentanyl exposure, monitor for respiratory depression.
- CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): Decreased fentanyl exposure, potentially leading to reduced efficacy or withdrawal symptoms.
- Anticholinergic drugs: Increased risk of urinary retention and/or severe constipation.
Minor Interactions
- Not available (most interactions are significant due to fentanyl's potency)
Monitoring
Baseline Monitoring
Rationale: To establish baseline pain level and characterize breakthrough pain episodes.
Timing: Prior to initiation of therapy and at each follow-up visit.
Rationale: To assess baseline respiratory function and identify risk factors for respiratory depression.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline neurological status and identify risk factors for excessive sedation.
Timing: Prior to initiation of therapy.
Rationale: To identify potential drug interactions that could increase risk of adverse effects.
Timing: Prior to initiation of therapy.
Rationale: Fentanyl lozenge is only for opioid-tolerant patients; confirm eligibility.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Regularly during titration and ongoing therapy (e.g., daily during titration, weekly/monthly once stable)
Target: Acceptable pain relief with tolerable side effects.
Action Threshold: Inadequate pain relief or excessive side effects warrant dose adjustment or re-evaluation.
Frequency: During titration, and regularly during stable therapy (e.g., at each visit, patient/caregiver education for home monitoring)
Target: Normal respiratory rate and effort for the patient.
Action Threshold: Respiratory rate <10 breaths/min, shallow breathing, excessive sedation, or unresponsiveness requires immediate medical intervention (e.g., naloxone, emergency services).
Frequency: During titration and ongoing therapy
Target: Alert and able to communicate, or easily aroused.
Action Threshold: Excessive drowsiness, difficulty arousing, or unresponsiveness requires intervention.
Frequency: Regularly (e.g., at each visit)
Target: Regular bowel movements.
Action Threshold: Constipation requires prophylactic or therapeutic management.
Frequency: Regularly (e.g., at each visit, through urine drug screens if indicated)
Target: Adherence to prescribed regimen, no signs of misuse.
Action Threshold: Suspicion of OUD or diversion requires intervention and referral.
Symptom Monitoring
- Severe drowsiness
- Dizziness
- Confusion
- Slow or shallow breathing
- Difficulty breathing
- Pinpoint pupils
- Extreme fatigue
- Unresponsiveness
- Nausea
- Vomiting
- Constipation
- Itching
Special Patient Groups
Pregnancy
Use during pregnancy is generally not recommended due to potential for fetal harm, including neonatal opioid withdrawal syndrome (NOWS). Benefits must clearly outweigh risks.
Trimester-Specific Risks:
Lactation
Fentanyl is excreted into breast milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., sedation, respiratory depression, poor feeding), breastfeeding is not recommended during treatment with fentanyl lozenge. If breastfeeding cannot be avoided, monitor the infant closely for signs of sedation and respiratory depression.
Pediatric Use
Safety and efficacy have not been established in pediatric patients under 16 years of age. Use in opioid-tolerant adolescents 16 years and older should follow adult titration guidelines with extreme caution and close monitoring due to potential for increased sensitivity to respiratory depression.
Geriatric Use
Elderly patients may be more sensitive to the effects of fentanyl, particularly respiratory depression. Start with lower doses and titrate slowly. Monitor closely for adverse effects, especially respiratory depression and sedation. Consider age-related decreases in renal and hepatic function.
Clinical Information
Clinical Pearls
- Fentanyl lozenge is for opioid-tolerant cancer patients only. Use in opioid-naΓ―ve patients can be fatal due to severe respiratory depression.
- Strict adherence to the REMS (Risk Evaluation and Mitigation Strategy) program is mandatory for prescribing, dispensing, and patient counseling.
- Patients and caregivers must be educated on the signs of respiratory depression and the availability and use of naloxone.
- Accidental ingestion by children or pets is a significant risk and can be fatal. Emphasize secure storage and proper disposal.
- Dose titration is crucial; start low and go slow, assessing efficacy and tolerability for each breakthrough pain episode.
- Only one lozenge should be used per breakthrough pain episode. Do not use more than 4 doses per day.
- Patients should not chew, suck, or swallow the lozenge whole, as this will reduce the transmucosal absorption and may lead to lower efficacy or delayed onset.
Alternative Therapies
- Other short-acting opioids for breakthrough pain (e.g., immediate-release oxycodone, hydromorphone, morphine)
- Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for mild-moderate pain or as adjuncts
- Adjuvant analgesics (e.g., gabapentin, pregabalin, tricyclic antidepressants) for neuropathic pain
- Regional nerve blocks or other interventional pain procedures
- Radiation therapy for localized cancer pain
Cost & Coverage
General Drug Facts
This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. It is vital to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider.
In the event of an overdose, a medication called naloxone can be administered to help counteract the effects. Discuss obtaining and using naloxone with your doctor or pharmacist. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide detailed information about the overdose, including the substance taken, the amount, and the time it occurred.
In case of a suspected overdose, contact your local poison control center or seek emergency medical care immediately. When seeking help, be prepared to provide information about the substance involved, the quantity taken, and the time of the incident.